3-[2-(3-ChIorophenyI)ethyI]-2-pyridinecarbonitriIe 99%

Welcome to Aptra Synthesis Private Limited, a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates. Our establishment was founded with a core vision: to become the foremost preferred API supplier in the global pharmaceutical market. Our relentless pursuit of this vision hinges on a dual commitment to quality and affordability.

At Aptra Synthesis Private Limited, we drive this commitment by drawing upon deep-seated industry expertise, a highly qualified team of professionals characterized by their integrity, and advanced infrastructure. These factors, in turn, enable us to forge enduring and robust business partnerships on a global scale. Aptra Synthesis Private Limited (ASPL) is strategically poised to accommodate substantial production capacity, meticulously aligned with international and national regulatory standards. Moreover, our production capacity holds the potential for substantial scalability, ensuring adaptability to future demands. Our overarching vision and mission revolve around furnishing premium-quality products that deliver unparalleled value, all while upholding superior customer service that remains accessible around the clock.